Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

January 30, 2023

Study Completion Date

January 30, 2023

Conditions
Major Depressive Disorder
Interventions
OTHER

Pathway Platform mobile app

The pathway platform intervention involves 3 components: 1. The patient facing app which will: a) Gather health information related to depression management and patient-Provider engagement. b) Clinical data collection; PHQ-9, WHO-5, PDQ-D-5, medication adherence and side effects, goal setting and goal tracking. c) Research data; Patient Activation Measure -13\[PAM-13\], CollaboRATE, and Work and Social Adjustment Scale \[WSAS\]. 2. Electronic Medical Record Integration - a) Data collected in the app is accessible to care team in real time. b) Provide a longitudinal summary to assist in decision making and depression management. 3. Educational Scaffolding - a) Training program describing how the Pathway Platform can support care team members in clinical processes related to measurement-based care and shared-decision making. b) Includes ongoing feedback with up to three audit cycles.

Trial Locations (1)

60453

Advocate Christ Medical Center, Oak Lawn

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

Lundbeck LLC

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER